Stock AMGN34 AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Amgen Inc. Sao Paulo

Equities

AMGN34

BRAMGNBDR004

Market Closed - Sao Paulo
Other stock markets
 20:29:55 24/05/2024 BST 		5-day change 1st Jan Change
56.88 BRL +0.21% Intraday chart for Amgen Inc. -0.68% +13.87%
05-22 Sandoz: Marketing authorization for Wyost and Jubbonti in the EU CF
05-22 Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test MT

Chart calendar Amgen Inc.

d031d01ba98df.TEu8sJLxkRCiIbEzz9U5XalEqZdNpI7dxf7S0wKz_rY.AyHX-PfFo1-Pb_JL_eddP8Yj8_4a79nogYqllW2FzOA8EvH34oChc-dm5A~4722f7eb1899f8f768fabd9c8b744651

Upcoming events on Amgen Inc.

31/05/2024 19:00 Annual General Meeting
29/07/2024 Q2 2024 Earnings Release (Projected)
28/10/2024 Q3 2024 Earnings Release (Projected)
03/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Amgen Inc.

21/05/2024 22:15 American Thoracic Society Conference - Reduced Mucus Plugging with Tezepelumab
21/05/2024 22:15 American Thoracic Society Conference - Asthma Exacerbation Rates as a Function
21/05/2024 19:30 American Thoracic Society Conference - Patient Characteristics and Treatment Patterns
21/05/2024 19:30 American Thoracic Society Conference - Effect of Tezepelumab on Exercise Tolerance
21/05/2024 19:30 American Thoracic Society Conference - Efficacy of Tezepelumab in Black or African American Patients
21/05/2024 19:30 American Thoracic Society Conference - Efficacy of Biologics for Reducing
21/05/2024 19:30 American Thoracic Society Conference - Effect of Biologics on Biomarkers
21/05/2024 19:30 American Thoracic Society Conference - Poster Session No. C34
21/05/2024 19:30 American Thoracic Society Conference - Poster Session No. C31
20/05/2024 21:00 American Thoracic Society Conference
20/05/2024 17:50 American Thoracic Society Conference - Session No. B13
20/05/2024 17:15 American Thoracic Society Conference
19/05/2024 22:15 American Thoracic Society Conference - Phase 1 Safety and Efficacy of AZD8630/AMG104
19/05/2024 22:15 American Thoracic Society Conference - Greater Exacerbation Reductions with Earlier Biologic Initiat
19/05/2024 22:15 American Thoracic Society Conference - Session No. A101
19/05/2024 17:15 American Thoracic Society Conference - Efficacy and Safety of Avacopan Versus
14/05/2024 17:20 Bank of America Merrill Lynch Global Healthcare Conference
02/05/2024 21:30 Q1 2024 Earnings Call
02/05/2024 21:01 Q1 2024 Earnings Release
10/03/2024 00:50 American Academy of Dermatology Meeting

Past dividends on Amgen Inc.

15/05/2024 Quarterly 2.25 USD
14/02/2024 Quarterly 2.25 USD
15/11/2023 Quarterly 2.13 USD
16/08/2023 Quarterly 2.13 USD
16/05/2023 Quarterly 2.13 USD
13/02/2023 Quarterly 2.13 USD
15/11/2022 Quarterly 1.94 USD
16/08/2022 Quarterly 1.94 USD
15/05/2022 Quarterly 1.94 USD
13/02/2022 Quarterly 1.94 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		23 362
23 196
0.71%		25 424
25 363
0.24%		25 979
25 999
-0.08%		26 323
26 247
0.29%		28 190
28 108
0.29%
33 001

EBITDA
Million USD		Released
Forecast
Spread 		13 363
13 029
2.56%		15 935
15 167
5.06%		15 822
16 002
-1.12%		16 178
15 935
1.53%		17 470
16 351
6.84%
18 668

EBIT
Million USD		Released
Forecast
Spread 		11 157
11 138
0.17%		12 334
12 315
0.15%		12 424
12 479
-0.44%		12 761
12 728
0.26%		13 399
13 423
-0.18%
14 768

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		9 138
9 499
-3.8%		8 133
8 782
-7.39%		6 701
6 379
5.04%		7 346
7 466
-1.6%		7 855
8 859
-11.33%
4 605

Net income
Million USD		Released
Forecast
Spread 		7 842
7 850
-0.1%		7 264
7 163
1.41%		5 893
5 598
5.27%		6 552
6 525
0.41%		6 717
7 401
-9.24%
4 133

EPS
USD		Released
Forecast
Spread 		12,9
12,8
0.4%		12,3
12,0
2.4%		10,3
9,84
4.5%		12,1
12,1
0.41%		12,5
13,8
-9.66%
7,93

Announcement Date30/01/2002/02/2107/02/2231/01/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		6 238
6 111
2.08%		6 594
6 526
1.04%		6 652
6 556
1.47%		6 839
6 766
1.08%		6 105
6 177
-1.17%		6 986
6 680
4.58%		6 903
6 948
-0.65%		8 196
8 106
1.11%		7 447
7 453
-0.08%
8 321


8 434


8 808


8 099


8 592

EBITDA
Million USD		Released
Forecast
Spread 		3 981
3 747
6.24%		4 163
3 953
5.31%		4 114
4 068
1.13%		3 920
3 744
4.7%		3 721
3 684
1.01%		4 411
4 152
6.25%		4 298
4 443
-3.25%		5 040
4 568
10.32%		4 477
4 373
2.37%
5 147


5 302


5 053







EBIT
Million USD		Released
Forecast
Spread 		3 140
2 939
6.84%		3 335
3 152
5.8%		3 277
3 201
2.39%		3 009
2 976
1.11%		2 821
2 879
-2.01%		3 515
3 292
6.77%		3 403
3 424
-0.62%		3 660
3 689
-0.78%		3 078
3 164
-2.71%
3 790


3 910


4 019


3 657


3 975

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		1 675
2 243
-25.32%		1 531
2 046
-25.18%		2 392
2 021
18.36%		1 748
1 866
-6.32%		3 442
2 294
50.04%		1 614
2 402
-32.81%		1 947
2 183
-10.81%		852
1 517
-43.85%		-68,0
1 214
-105.6%
1 558


1 584


1 539


2 599


2 985

Net income
Million USD		Released
Forecast
Spread 		1 476
1 725
-14.42%		1 317
1 749
-24.72%		2 143
1 665
28.68%		1 616
1 686
-4.16%		2 841
1 479
92.11%		1 379
1 840
-25.04%		1 730
1 772
-2.38%		767
1 308
-41.36%		-113
1 127
-110.03%
1 263


1 287


1 154


1 663


1 996

EPS
USD		Released
Forecast
Spread 		2,68
3,24
-17.27%		2,45
3,28
-25.3%		3,98
3,06
30.15%		3,00
3,21
-6.6%		5,28
2,98
77.12%		2,57
3,40
-24.34%		3,22
3,29
-2.1%		1,42
2,36
-39.72%		-0,21
2,71
-107.75%
2,50


2,74


2,50


3,11


3,74

Announcement Date27/04/2204/08/2203/11/2231/01/2327/04/2303/08/2331/10/2306/02/2402/05/24-----

Upcoming sector events for Amgen Inc.

24/05/2024 BLUE JET HEALTHCARE LIMITED: Q4 2024 Earnings Release
24/05/2024 AUROBINDO PHARMA: Q4 2024 Earnings Release
24/05/2024 DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release
26/05/2024 CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release
26/05/2024 NATCO PHARMA LIMITED: Q4 2024 Earnings Release
27/05/2024 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
28/05/2024 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
28/05/2024 FDC LIMITED: Q4 2024 Earnings Release (Projected)
28/05/2024 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
28/05/2024 PFIZER LIMITED: Q4 2024 Earnings Release
More events

Past sector events for Amgen Inc.

Today TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
Today SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release
23/05/2024 15:47 ORCHID PHARMA LIMITED: Q4 2024 Earnings Release
22/05/2024 SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release
22/05/2024 13:06 GLAND PHARMA LIMITED: Q4 2024 Earnings Release
21/05/2024 11:57 ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release
20/05/2024 22:00 TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release
17/05/2024 13:52 J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
17/05/2024 09:28 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
15/05/2024 15:05 MANKIND PHARMA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. AMGN34 Stock
  5. Calendar Amgen Inc.